This group revealed elevated levels of both the OTUD7B and LSD1 proteins in breast cancer patients and reported that these elevated levels were associated with advanced tumor stage, lymph node metastasis, and poor overall survival outcomes. Here, OTUD7B is linked to breast cancer.